Application and Funding Trends in Fiscal Year 2020

On December 27, 2020, the Consolidated Appropriations Act, 2021, was signed into law. The appropriation provides NIGMS with a budget of $2,991,417,000, in Fiscal Year (FY) 2021, a 1.8% increase over the FY 2020 appropriation. With this increased budget, NIGMS is committed to providing taxpayers with the best possible returns on their investments in fundamental biomedical research. As part of this commitment to stewardship, we regularly monitor trends in our funding portfolio. NIGMS maintains a diversified biomedical research portfolio, supporting a wide range of topics and investigators. NIGMS and NIH programs and policies aim to increase the number of funded investigators and to maintain researchers’ funding stability over time. In this post, we describe NIGMS investigator-level trends for selected R01-equivalent grants as well as overall research project grant (RPG) trends for FY 2020 compared to previous fiscal years. NIGMS Investigator-Level Trends for Research Grants In line with our strategic objective of supporting a broad and diverse group of investigators, we consistently monitor two metrics that describe our investigator pool: the number of early stage investigators (ESIs) and the cumulative investigator rate. Increasing the number of newly supported ESIs is integral to the continued success of the biomedical research enterprise. Figure 1 illustrates the number of ESIs who received their first NIGMS competing...
Source: NIGMS Feedback Loop Blog - National Institute of General Medical Sciences - Category: Biomedical Science Authors: Tags: Director’s Messages Funding Trends Funding Outcomes Funding Policies MIRA NIGMS Strategic Plan R01 Source Type: blogs